Sathlokhar Synergys E&C Reports 121% Revenue Growth in FY26; Eyes 70% Surge in FY27
Sathlokhar Synergys E&C Global reports ₹823.56 Cr revenue in FY26, a 121% increase. Management targets 70% growth in FY27 driven by new PEB manufacturing.
FY26 Results
Latest FY26 Results stock news from NSE and BSE filings, 11 stories so far.
Earning Call
Uniparts India FY26 Revenue Grows 21% to ₹1,188 Cr; Net Profit Jumps 80% YoY
Uniparts India reports strong FY26 results with 21% revenue growth to ₹11,880 Mn and 80% PAT growth, exceeding management's mid-teens growth guidance.
Earning Call
Samhi Hotels Reports 12.3% Income Growth in FY26; Targets 60% Upscale Revenue Share
Samhi Hotels (SAMHI) reports FY26 income of ₹12,790 mn, a 12.3% YoY growth. Management focuses on upscale expansion and deleveraging to 3.0x Net Debt/EBITDA.
Earning Call
DOMS Industries Records 21.6% FY26 Revenue Growth, Plans ₹275 Cr Capex for FY27
DOMS Industries reports FY26 revenue of ₹2,326.4 Cr, up 21.6% YoY. Management guides for 17-20% growth in FY27 alongside a ₹275 Cr capital expenditure plan.
Earning Call
Knowledge Realty Trust FY26 Review: NOI Surges 18% to ₹4,048 Crore
Knowledge Realty Trust (KRT) reports FY26 revenue of ₹4,600cr and an 18% jump in NOI. Distributions of ₹2,101.9cr exceeded initial IPO projections.
Earning Call
GE Power India FY26 Results: Revenue Climbs 21% to ₹1,269 Cr as Dividends Resume
GE Power India reports a 21% revenue jump to ₹1,269 crore for FY26, driven by core services growth and legacy settlements. Management resumes dividends at ₹7/share.
Earning Call
Onward Technologies FY26 Results: PAT Surges 72% as Revenue Hits Record ₹550 Crore
Onward Technologies reports record FY26 revenue of ₹550cr and 72.3% PAT growth. Digital services now contribute 50% of revenue as the company eyes AI-led growth.
Earning Call
UPL Ltd Reports 11% Revenue Growth in FY26 as PATMI More Than Doubles
UPL Ltd delivers 11% revenue growth to ₹51,839 Cr in FY26, with EBITDA margins expanding to 18.5%. Management achieves significant debt reduction of $850 million.
Earning Call
Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27
Emcure Pharmaceuticals reports ₹9,204 Cr revenue for FY26, surpassing the $1 billion mark. Management guides for margin expansion and domestic recovery in FY27.
